Home  >  Products  >  CTNNB1 (catenin (cadherin-associated protein), beta 1, 88kDa ) Blocking Peptide (the C terminal of CTNNB1)(100ug)
CTNNB1 (catenin (cadherin-associated protein), beta 1, 88kDa ) Blocking Peptide (the C terminal of CTNNB1)(100ug)

CTNNB1 (catenin (cadherin-associated protein), beta 1, 88kDa ) Blocking Peptide (the C terminal of CTNNB1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CTNNB1 Antibody (P100601_T100), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP30904
Size: 100ug
Weight: 85kDa
Gene: 1499
Format: Lyophilized powder
Target: The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Three transcript variants encoding the same protein have been found for this gene.
Alternative names: CTNNB; DKFZp686D02253; FLJ25606; FLJ37923
See Full Product Listings >